Björn Albrecht is a partner in McKinsey’s London office and works with pharmaceutical and biotech companies, health systems, payers and providers on cancer-related topics. He leads the McKinsey Cancer Center globally and is also a leader in their Pharmaceuticals & Medical Products Practice in Europe. He has a PhD in molecular oncology from the Ohio State University Comprehensive Cancer Center and a Leukemia and Lymphoma Society post-doctoral fellowship.
Björn’s work covers the whole value chain from early discovery strategies through clinical development to commercialization and reimbursement for cancer medicines. In addition, he supports health systems leaders and manufacturers in defining “adequate outcome” approaches to cancer treatment and developing innovative collaborations to serve patients’ needs.
Björn also serves on the governing and advisory boards of multiple non-profit organizations active in the fight against cancer